Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · IEX Real-Time Price · USD
2.290
+0.030 (1.33%)
At close: May 17, 2024, 4:00 PM
2.340
+0.050 (2.18%)
After-hours: May 17, 2024, 7:59 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $7.33 million as of May 17, 2024. Its market cap has decreased by -26.00% in one year.
Market Cap
7.33M
Enterprise Value
6.60M
1-Year Change
-26.00%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $7.33M, a decrease of -92.92%. That is a compound annual growth rate of -53.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 7.40M | 1.37% |
May 16, 2024 | 7.30M | 4.29% |
May 15, 2024 | 7.00M | -12.50% |
May 14, 2024 | 8.00M | 45.45% |
May 13, 2024 | 5.50M | -5.17% |
May 10, 2024 | 5.80M | -3.33% |
May 9, 2024 | 6.00M | -7.69% |
May 8, 2024 | 6.50M | -1.52% |
May 7, 2024 | 6.60M | 1.54% |
May 6, 2024 | 6.50M | -9.72% |
May 3, 2024 | 7.20M | - |
May 2, 2024 | 7.20M | 4.35% |
May 1, 2024 | 6.90M | - |
Apr 30, 2024 | 6.90M | -2.82% |
Apr 29, 2024 | 7.10M | - |
Apr 26, 2024 | 7.10M | 5.97% |
Apr 25, 2024 | 6.70M | -4.29% |
Apr 24, 2024 | 7.00M | -2.78% |
Apr 23, 2024 | 7.20M | - |
Apr 22, 2024 | 7.20M | -2.70% |
Apr 19, 2024 | 7.40M | 1.37% |
Apr 18, 2024 | 7.30M | - |
Apr 17, 2024 | 7.30M | -1.35% |
Apr 16, 2024 | 7.40M | -2.63% |
Apr 15, 2024 | 7.60M | 5.56% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Telesis Bio | 7.41M |
PolyPid | 7.34M |
Intelligent Bio Solutions | 7.29M |
ASLAN Pharmaceuticals | 7.27M |
Oragenics | 7.24M |
Cadrenal Therapeutics | 7.01M |
Tenax Therapeutics | 6.99M |
Enveric Biosciences | 6.98M |